- This event has passed.
“Cardiology Developments 2023-2024” (Virtual Event)
George Dangas, M.D., PhD
Professor of Medicine & Surgery; Director of Cardiovascular Innovation & Transcatheter Cardiovascular Therapeutics; Chief of Cardiology
Icahn School of Medicine at Mount Sinai, New York
George D. Dangas, MD, PhD, MACC, MSCAI, is a:
- Professor of Medicine (Cardiology) & Surgery (Vascular) at Icahn School of Medicine & the Mount Sinai Hospital in New York
- Director of Cardiovascular Innovation at Mt Sinai Hospital
- Chief of Cardiology
- Director of Transcatheter Cardiovascular Therapeutics (TCT)
- Textbook Editor for Interventional Cardiology Principle & Practice (Wiley Publishers, UK)
- Chair of the American Heart Association (AHA) Invasive Cardiology Committee
- President of the Society for Cardiovascular Angiography & Interventions (SCAI) 2023-24
Dr. Dangas is a leading authority in the performance of minimally invasive heart disease and vascular interventions, such as stent, angioplasty, atherectomy and heart valve repair/replacement with both established and novel techniques.
After studies at National Kapodistrian University of Athens, he served as Medical Officer for the Hellenic Navy and then trained in Medicine at Brown University/Miriam Hospital, after which he completed a Fellowship in Cardiology and Interventional at Mount Sinai.
Among the 5 founding physicians of Cardiovascular Research Foundation in NYC, he was a key faculty at Lenox Hill & Columbia University Medical Center and led the establishment of an Interventional Fellowship Program at both locations.
He served as Trustee of ACC & SCAI, Fellow of ESC & AHA, founder of ACC Interventional Council/Section, Cardiology Chair at Onassis Heart Center and Chair of the AHA Laennec Society.
He is a Master of ACC and of SCAI, JACC Section Editor, 2019 ACC Distinguished Fellow, 2017 Teacher of the Year, and included in many Super Doctors & WHOisWHO lists for over 10 years.
Objectives
- Assess advances in structural heart disease.
- Appraise developments in cardiac medical therapy.
- Revise evolution of interventional cardiology concepts.
Faculty Disclosure:
- Dr. Dangas has indicated the following relevant financial relationships with commercial interests:
- Financial Relationship – Grant or Research Support
- Commercial Interest / Organization – Daiichi Sankyo, Inc.
Planning Committee Disclosure:
Dr. Deshpande has indicated that he has no relevant financial relationships with commercial interests.
Dr. Weiss has indicated the following relevant financial relationships with commercial interests:
- Financial Relationship – Consultant/Contractor
- Commercial Interest / Organization – Prizm LLC
Target Audience
Primary care physicians.
Accreditation
The University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
The University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.”